Overview
Lucas Kriegl-Janeschitz practices in Basel, Switzerland. Mr. Kriegl-Janeschitz is rated as an Experienced expert by MediFind in the treatment of Giant Papillary Conjunctivitis. His top areas of expertise are Stargardt Macular Degeneration, Late-Onset Retinal Degeneration, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.
His clinical research consists of co-authoring 20 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Giant Papillary Conjunctivitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Stargardt Macular DegenerationMr. Kriegl-Janeschitz isAdvanced. Learn about Stargardt Macular Degeneration.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Kriegl-Janeschitz isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Allergic ConjunctivitisMr. Kriegl-Janeschitz isExperienced. Learn about Allergic Conjunctivitis.
- Cone-Rod DystrophyMr. Kriegl-Janeschitz isExperienced. Learn about Cone-Rod Dystrophy.
- EsotropiaMr. Kriegl-Janeschitz isExperienced. Learn about Esotropia.
- Geographic AtrophyMr. Kriegl-Janeschitz isExperienced. Learn about Geographic Atrophy.
- Giant Papillary ConjunctivitisMr. Kriegl-Janeschitz isExperienced. Learn about Giant Papillary Conjunctivitis.